Gas Calorimeter Market Share Projected to Grow at a 5.14% 1-02-2023, 18:10

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21

Bitget Burns 30M BGB Worth $138 Million for Q2 2025 10-07-2025, 12:10